Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: GenesiDol for the Management of Musculoskeletal Pain [NA]

View source ↗

Summary

A clinical trial update reports GenesiDol for musculoskeletal pain, with the study associated with inflammatory bowel disease and currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GenesiDol

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Inflammatory Bowel Diseases | NA | Status: NOT_YET_RECRUITING